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ABSTRACT                      The effect of 4-aminopyridine (4-AP), a known inhibitor of voltage-dependent
K+ channels (KV), was studied on the resting vasomotor tone in porcine and human coronary
arteries. Isolated coronary artery preparations were suspended in organ bath for isometric
tension recordings. 4-AP (1.25x10-8 - 5.8x10-4 M) caused concentration-dependent contractions
both in porcine and human coronary arteries. The EC50 values obtained with 4-AP did not differ
significantly in porcine and human coronary preparations (-4.54 logM and -4.37 logM,
respectively). Loading the amine stores of the coronary tissues with 1 mM noradrenalin or
blocking the beta-receptors with 2 µM propranolol did not change the contractile effects of
4-AP. In contrast, loading the isolated blood vessels with 1 mM 5-hydroxytryptamine (5-HT)
resulted in significantly higher contractions, when induced by micromolar concentrations of
4-AP. The 5-HT receptor blocker, methysergide, almost completely inhibited these contractions.
Our present observation provides evidence for the functional role of KV in setting the
vasomotor tone of coronary arteries through the release of 5-HT. In the light of these findings
we suggest that the porcine coronary artery preparation can serve as a model for studying the
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Potassium channels are the most widely distributed ion
channels in vascular tissues and these ion channels have been
shown to play important roles in the regulation of the cell
membrane potential (Nelson and Quayle 1995). In the arterial
smooth muscle four main types of K+ channels have been
identified: the voltage-dependent K+ channel (KV), the Ca2+
activated K+ channel (KCa), the inward rectifier K+ channel
(KIR) and the ATP-sensitive K+ channel (KATP) (Nelson and
Quayle 1995). The functional role of these potassium chan-
nels in the modulation of coronary vasomotor tone has not
yet been characterised.
Diameter of blood vessels is largely determined by the
interactions between the smooth muscle and endothelial cells
as well as the medio-adventitial neurons through the liber-
ation of vasoactive mediators. All of these sites in the blood
vessel wall have been shown to contain KV channels (Hara
et al. 1980; Takeda et al. 1987; Adams 1994; Halliday et al.
1995; Knot and Nelson 1995; Gollasch et al. 1996; O’Rourke
1996; Fryer and Glover 1997; Ishikawa et al. 1997). KV
channels have been presented to be responsible for maintain-
ing the resting membrane potential of coronary smooth
muscles and the activation of KV channels was inhibited by
4-aminopyridine (4-AP) (O’Rourke 1996; Ishikawa et al.
1997). Blocking of KV channels located on the membrane of
nerve endings was suggested to affect the tone of blood
vessels via the release of vasoconstrictor neurotransmitters
(Hara et al. 1980; Fryer and Glover 1997). The involvement
of vasoactive mediators in the function of KV channels,
however, is not known in coronary arteries. In porcine
coronary artery 5-HT is an important modulator of the blood
vessel tone (Cushing and Cohen 1992). In the same species,
the role of some vasoactive mediators in the contractile effect
of 4-AP was excluded but a possible mediation through the
liberation of 5-HT was not studied (O’Rourke 1996).
In this study we investigated the effect of the K
V
 blocker,
4-AP, on the resting tone of porcine and human coronary
arteries and the possible role of noradrenalin and 5-HT in
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Materials and methods
Tissue preparation and experimental protocol
Human coronary arteries were obtained from heart transplants
without coronary artery disease with the permission of the Ethical
Committee of the Albert Szent-Györgyi Medical University (51-57/
1997.O.E.j., 16.05.1997.). The hearts were stored in cardioplegic
solution at 4°C and used for the experiments within 12 hours.
Porcine hearts of either sex were obtained from a local slaugh-
terhouse and were transported to the laboratory in Krebs-Hensenleit
solution (KHS) at 4°C. The epicardial coronary arteries of human
and porcine  hearts were carefully removed, cleaned from the
adhering connective tissue and the blood vessels were cut into 5
mm ring segments.
Rings were placed into an organ bath filled with KHS and were
aerated with a mixture of 95% O2 and 5% CO2 at 37°C. The
isometric tension was recorded with a force-displacement trans-
ducer (Type F30, Hugo Sachs Elektronic, Germany). Mechanical
responses of arterial rings were displayed by means of a pen
recorder (Type 175, KUTESZ, Hungary). Strips were stretched
passively (porcine coronary artery rings 30 mN, human coronary
artery rings 10 mN), and equilibrated for 45 min, during which the
medium was changed every 15 min. Endothelium of porcine
coronary arteries was removed mechanically, i.e. thin glass stick
covered with cotton wool was pulled through the rings. The absence
of endothelium was confirmed by the lack of relaxation in response
to the endothelium dependent vasodilator bradykinin (10-6 M).
Concentration-response curves to 4-aminopyridine (4-AP,
1.25x10-8 - 5.8x10-4M) were obtained by adding the drug in a
cumulative manner to the organ bath at the end of the equlibration
period. After contraction induced by 4-AP the preparation was
washed three times and incubated with either 1 mM noradrenalin
(NA) or 1 mM 5-hydroxytryptamine (5-HT) for 10-30 min. After
this treatment coronary artery rings were washed again, and the
changes of basal tone by repeated administration of 4-AP were
detected. In some experiments, contractile responses of 4-AP were
investigated in the presence of  S-propranolol (2 µM, before and
after NA treatment) and methysergide (100 µM, after 5-HT treat-
ment) to inhibit β-adrenergic receptors and 5-HT receptors,
respectively.
Drugs
Drugs used in the present study were 4-AP, 5-HT, creatinine sulfate
complex, S-propranolol hydrochloride (Sigma), L-Noradrenalin-L-
tartarat (Merck) and methysergide (Sandoz). These drugs were
diluted in distilled water. Cardioplegic solution had the following
composition (in mM): NaCl 110, KCl 16, MgCl2 16, CaCl2 1.2,
NaHCO3 10 (REANAL, Hungary). The composition of the KHS
was as follows (in mM): NaCl 120, NaHCO3 20, KCl 4.1, KH2PO4
1.2, MgCl2x6H2O 1.2, CaCl2 1.5, glucose 11 (pH 7.4) (REANAL,
Hungary).
Statistics
Contractile responses of human and porcine coronary arteries were
expressed as milliNewton (mN). The concentrations and EC50
values (the concentration having half of the maximum effect) were
expressed in -log molar (logM) concentration. Results are presented
as means ± SEM (standard error of the mean). n = the number of
animals from which vessels were taken. Values of corresponding
concentrations were compared by one-way ANOVA, followed by
Bonferroni post-hoc test and were considered as significantly
different at p<0.05. Nonparametric Wilcoxan-test was used for the
evaluation of the data in the case of methysergide treatment and
were considered as significantly different at p<0.05.
Results
4-AP, an inhibitor of KV, increased the basal tone of porcine
coronary artery preparations concentration dependently in
low micromolar concentrations (Fig. 1, filled circle, panel A,
before NA). Pretreatment of the same preparations with 1
mM noradrenalin (NA) did not result in an enhanced con-
traction to 4-AP (before NA: 16.2 ± 6.4 mN, filled circle,
panel A; after NA: 8 ± 3.1 mN, filled circle, panel B, not
significant, n = 9, Fig. 1). The β-adrenoceptor blocker S-
propranolol did not modulate the contraction induced by 4-
AP either before or after NA treatment (Fig. 1, open circle,
panel A and B, n = 9).
In contrast to this observation, after pretreatment of
coronary arteries with 1 mM 5-hydroxytryptamine (5-HT)
contraction to 4-AP became significantly higher compared
to non-treated ones (before 5-HT: 12.2 ± 3.8 mN, after 5-HT:
24 ± 3.5 mN, p<0.05, n = 7, Fig. 2). The nonselective 5-HT
receptor blocker, methysergide, almost completely abolished
the contractions (Fig. 3, n = 7).
4-AP also could induce dose-dependent contraction in the
human coronary artery (Fig. 4, n = 5). In human coronary
preparations, uptake of 5-HT resulted in an enhanced con-
traction — similar to porcine coronary artery — and meth-
ysergide was able to reverse the effect of 4-AP (Fig. 5,
representative figure).
As shown in Table 1, neither the treatment with NA nor
presence of S-propranolol influenced the EC50 values of 4-
AP in porcine coronary arteries. Treatment with 5-HT
significantly increased the sensitivity to 4-AP of porcine
coronary preparations. The EC50 values were similar in
untreated porcine and human coronary arteries (-4.54 ± 0.1
logM and -4.37 ± 0.18 logM, respectively).
Discussion
The results of the present investigations demonstrate that the
KV channel blocker, 4-aminopyridine (4-AP), induces con-
traction of porcine and human coronary arteries via the
release of vasoconstrictor 5-HT. These results are in agree-
ment with previous studies that regulation of membrane
potential through activation or inhibition of KV channel
activity provides an important mechanism to dilate or
constrict arteries. Indeed, the importance of potassium
conductance in maintaining the resting vasomotor tone has
suggested that potassium channel blockers are able to cause
contractions of smooth muscles. This contractile effect of 4-
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AP on some blood vessels have been recently characterized
(Hara et al. 1980; Halliday et al. 1995; Knot and Nelson
1995; O’Rourke 1996; Fryer and Glover 1997; Ishikawa et
al. 1997). The role of KV channels in setting the coronary tone
of some animal species is also well studied (O’Rourke 1996;
Ishikawa et al. 1997). Vascular smooth muscle cells of human
coronary artery have also been shown to contain KV channels
(Gollasch et al. 1996). In an earlier study 4-AP was demon-
strated to enhance the basal tone of human coronary artery
as well (Uchida et al. 1986). Our observation provides
evidence that the KV channel is a functionally important
channel not only in the porcine but in human coronary artery.
In our experiments, the contraction induced by blocking
of KV by 4-AP depends on the release of vasoconstrictor 5-
hydroxytryptamine (5-HT). Inhibition of KV channel by 4-
AP present on the sympathetic nerve fibers induces mem-
brane depolarisation, and this change of membrane potential
causes transmitter release and thus smooth muscle con-
traction (Hara et al. 1980; Fryer and Glover 1997). The
arteries are innervated by adrenergic nerves and these nerves
are able to accumulate 5-HT. From these perivascular sympa-
thetic nerve endings 5-HT, as vasoconstrictor co-transmitter
with noradrenalin (NA) were shown to be released (Cohen
1985; Saito and Lee 1987; Szabó et al. 1991). Under our
experimental conditions, the role of adrenergic innervation
is not likely to be important in the contractile effect of 4-AP,
because the presence of S-propranolol (both before and after
NA treatment) did not modulate the contraction induced by
4-AP. Moreover, loading the isolated porcine coronary
preparation with noradrenalin (NA) could not increase the
tone after administration of the potassium channel blocker.
This consists with the previous observation, that in porcine
coronary artery neither alpha-receptor blocker phentolamine
nor beta-receptor blocker propranolol modulated the con-
traction induced by 4-AP (O’Rourke 1996). Moreover, alpha-
1 adrenoreceptor appears to have no significant role in the
modulation of the tone of this blood vessel. It is well known
that NA released from sympathetic nerve endings can cause
vasorelaxation via beta adrenoreceptor stimulation (Horst
and Robinson 1985; Quillen et al. 1992). In our preliminary
experiments, in human coronary artery either these adrenerg
antagonist agents or NA treatment also did not modulate the
contractile effect of 4-AP (unpublished data). This corre-
sponds with observation that in human coronary artery
contraction induced by 4-AP was not eliminated by phen-
tolamine or yohimbine (Uchida et al. 1986).
Figure 1.  Effect of 4-aminopyridine (4-AP) on the basal tone and the influence of the loading of coronary tissue with noradrenalin (NA) on
the elevated tone induced by 4-AP. S-propranolol (S-prop) did not change the 4-AP induced tone in pig coronary artery. A represents before,
and B after pretreatment the coronary preparations with NA. Data represent mean ± SEM. n=9; • = 4-AP,    o = 4-AP + S-prop.
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Concerning the role of 5-HT, pretreatment of coronary
arteries with 1 mM 5-HT, 4-AP induced significantly higher
contraction and methysergide abolished this contraction both
in porcine and in human preparations. This suggested an
intact 5-HT storage capacity and intact uptake mechanism of
coronary arteries under our experimental conditions. It
should be emphasized that the source of 5-HT would be not
only the perivascular nerves but extraneuronal stores, too. In
earlier study it has been demonstrated that 5-HT accumu-
lation in the rat coronary circulation is mainly extraneuronal
and the mechanism of this uptake of 5-HT is similar to that
of NA (Bryan et al. 1989). Thus, extraneuronal 5-HT stores
may also be responsible for the contraction by 4-AP.
Figure 2. Effect of pretreatment with 5-hydroxytryptamine (5-HT)
on the elevated tone by 4-aminopyridine (4-AP) in pig coronary artery.
Data represent mean ± SEM. n = 7; * p<0.05; • = before 5-HT,   o =
after 5-HT.
Figure 3. Effect of 100 µM Methysergide (Meth) on the elevated tone
by 4-aminopyridine (4-AP) in pig coronary artery after pretreatment
with 5-hydroxytryptamine. Data represent mean ± SEM. n = 7, *
p<0.05, • =  4-AP, o = 4-AP+Meth.
Figure 4. Effect of 4-aminopyridine (4-AP) on the basal tone of human
coronary artery. Data represent mean ± SEM. n = 5.
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Based on the present findings we propose that under
pathological conditions the neuronal and/or extraneuronal
stores of coronary arteries are filled with platelet-derived 5-
HT (Cohen 1985). This serotonin may subsequently contrib-
ute to an abnormal contractile responsiveness, i.e. vasospasm
of the coronary artery. The 5-HT stores of the blood vessel
wall may be strongly affected by drugs acting on KV-type
potassium channels and, conseqently influence the coronary
tone.
In our experiments, 4-AP induced 5-HT release was
effective even at low  micromolar concentrations. However,
4-AP was shown to exert smooth muscle contractions in
millimolar concentrations (Uchida et al. 1986; Halliday et al.
1995; Knot and Nelson 1995; Ishikawa et al. 1997). In central
and peripheral nerves, 4-AP blocked KV also in low micro-
molar concentrations (Kumamoto and Kuba 1985; Hu and
Fredholm 1991) which corresponds to the potency of the
drug in the present study. The EC50 value of 4-AP was lower
in the absence of 5-HT loading compared to the value
obtained after pretreatment of the coronary preparations with
5-HT. We do not know the exact explanation of this change
in EC50, but we think that a larger mass of 5-HT released from
the coronary artery after loading masks the direct contractile
effect of 4-AP on the smooth muscle. It is well known that
5-HT is a very potent vasoactive mediator with EC50 of lower
than 1 µM (Cushing and Cohen 1992).
Figure 5. Effect of Methysergide on 5-hydroxytryptamine (5-HT) loaded human coronary artery in the presence of 4-aminopyridine. Data
represent mean ± SEM.
Table 1. Sensitivities of coronary arteries obtained from porcine and human coronary artery preparations to 4-AP.
              -log (M) EC50
        before NA after NA     before 5-HT after 5-HT untreated
Coronary preparation 4-AP         4-AP+S-prop          4-AP               4-AP+S-prop
Porcine 4.7 ± 0.1   4.47 ± 0.15            4.51 ± 0.14     4.39 ± 0.13          4.43 ± 0.14                 4.92 ± 0.06*            4.54 ± 0.1
Human —  —                          —               —             —                    —                        4.37±0.18
*Value after 5-HT treatment is significantly different from value before 5-HT treatment in porcine coronary artery (p<0.05). Untreated = before 5-HT + before NA
(4-AP). Each value represents the mean ± SEM. 4-AP: 4-aminopyridine, S-prop: S-propranolol, 5-HT: 5-hydroxytryptamine.
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Recently, the role of KV has been demonstrated in differ-
ent pathological conditions. Inhibition of KV was found to be
responsible for hypoxic pulmonary vasoconstriction (Post et
al. 1995), for Long QT-Syndrome and overexpression of KV
in pancreatic islet cells might cause diabetes (Grissmer
1997). These K+ channel dysfunctions have been termed as
“K+ channelopathies” (Grissmer 1997). This is the reason
why the exact mechanism of the KV channel blocker, 4-AP,
requires considerable attention. It has also been demonstrated
that pharmacological modulations of KV ion channels may
have potential value in the cardiac inotropic medication
(Varró and Papp 1995). The current findings suggest that 4-
AP  induces spasm of the coronary artery with consequent
ischemic damage of heart muscle. However, this potential
side effect of the KV channel inhibition on vascular tone
would be eliminated by introducing subtype selective inhi-
bition of KV channels in the heart (Iost et al. 1998).
In summary, the present findings provide pharmaco-
logical evidences that the KV channel plays a crucial role in
setting the resting vasomotor tone of porcine and human
coronary arteries via the regulation of the release of the
vasoconstrictor mediator, 5-HT. The pharmacodynamic
effect of 4-AP in the human coronary artery resembles that
obtained in the porcine coronary artery. This suggests that
coronary artery preparations obtained from the porcine heart
can serve as a model for studying the functional effect of
drugs on KV-type potassium channels.
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